Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farrelly

Showing results (711-720 of 747) with videos related to

Pageof 75
Sort By:
Nature Communications|November 27, 2019
LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcriptionHamed Yari, Lei Jin, Liu Teng, et al.
Elife|March 5, 2021
Sequential perturbations to mouse corticogenesis following in utero maternal immune activationCesar P Canales, Myka L Estes, Karol Cichewicz, et al.
Diabetes|December 29, 2005
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db miceThomas Harrity, Dennis Farrelly, Aaron Tieman, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 10, 2008
Lycotoxin-1 insecticidal peptide optimized by amino acid scanning mutagenesis and expressed as a coproduct in an ethanologenic Saccharomyces cerevisiae strainStephen R Hughes, Patrick F Dowd, Ronald E Hector, et al.
The Science of the Total Environment|July 24, 2024
The time for ambitious action is now: Science-based recommendations for plastic chemicals to inform an effective global plastic treatySusanne M Brander, Kala Senathirajah, Marina O Fernandez, et al.
Annals of Hematology|May 10, 2021
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the USFaith Davies, Robert Rifkin, Caitlin Costello, et al.
Science (New York, N.Y.)|April 11, 2020
Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seekingAshley E Lepack, Craig T Werner, Andrew F Stewart, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2009
Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonistsHao Zhang, Denis E Ryono, Pratik Devasthale, et al.
Cancers|April 3, 2021
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"Niamh M Keegan, Simon J Furney, Janice M Walshe, et al.
Pageof 75

Showing results (711-720 of 747) with videos related to

Sort By:
Pageof 75
Nature Communications|November 27, 2019
LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcriptionHamed Yari, Lei Jin, Liu Teng, et al.
Elife|March 5, 2021
Sequential perturbations to mouse corticogenesis following in utero maternal immune activationCesar P Canales, Myka L Estes, Karol Cichewicz, et al.
Diabetes|December 29, 2005
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db miceThomas Harrity, Dennis Farrelly, Aaron Tieman, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 10, 2008
Lycotoxin-1 insecticidal peptide optimized by amino acid scanning mutagenesis and expressed as a coproduct in an ethanologenic Saccharomyces cerevisiae strainStephen R Hughes, Patrick F Dowd, Ronald E Hector, et al.
The Science of the Total Environment|July 24, 2024
The time for ambitious action is now: Science-based recommendations for plastic chemicals to inform an effective global plastic treatySusanne M Brander, Kala Senathirajah, Marina O Fernandez, et al.
Annals of Hematology|May 10, 2021
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the USFaith Davies, Robert Rifkin, Caitlin Costello, et al.
Science (New York, N.Y.)|April 11, 2020
Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seekingAshley E Lepack, Craig T Werner, Andrew F Stewart, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2009
Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonistsHao Zhang, Denis E Ryono, Pratik Devasthale, et al.
Cancers|April 3, 2021
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"Niamh M Keegan, Simon J Furney, Janice M Walshe, et al.
Pageof 75